Literature DB >> 10547667

Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins.

W Zwerschke1, P Jansen-Dürr.   

Abstract

The E7 oncoprotein of human papillomavirus type 16 (HPV-16) has long been known as a potent immortalizing and transforming agent. However, the molecular mechanisms underlying cell transformation and immortalization by E7 remain largely unknown. It is believed that E7 exerts its oncogenic function at least in part by modulating cellular growth regulatory pathways. Increasing experimental evidence suggests that cell transformation by E7 is mediated by the physical association of E7 with cellular regulatory proteins, whose functions are specifically altered by E7, as exemplified by the well-known interaction of E7 with the retinoblastoma protein. In this review, we summarize the available data on the interaction of E7 with cellular regulatory factors and functional consequences of these interactions. We will focus the review on a set of recently identified new target proteins for the E7 oncoprotein, which sheds new light on E7 functions required for cell transformation and immortalization. Similar to the case of the E6 protein of HPV-16, whose interaction with p53 was long considered its major activity, it now appears that the interaction of E7 with the retinoblastoma protein represents just one of many distinct interactions that are relevant for cell transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10547667     DOI: 10.1016/s0065-230x(08)61022-2

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  27 in total

1.  Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.

Authors:  Thorarinn Gudjonsson; René Villadsen; Helga Lind Nielsen; Lone Rønnov-Jessen; Mina J Bissell; Ole William Petersen
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

2.  Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.

Authors:  L G Bermúdez-Humarán; P Langella; A Miyoshi; A Gruss; R Tamez Guerra; Roberto Montes de Oca-Luna; Yves Le Loir
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

3.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study.

Authors:  Daniela Ehehalt; Barbara Lener; Haymo Pircher; Kerstin Dreier; Heiko Pfister; Andreas M Kaufmann; Sergio Frangini; Sigrun Ressler; Elisabeth Müller-Holzner; Markus Schmitt; Daniela Höfler; Ursula Rostek; Andreas Kaiser; Andreas Widschwendter; Werner Zwerschke; Pidder Jansen-Dürr
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

5.  Differentiation potential of a basal epithelial cell line established from human bronchial explant.

Authors:  Skarphedinn Halldorsson; Valthor Asgrimsson; Ivar Axelsson; Gudmundur Hrafn Gudmundsson; Margret Steinarsdottir; Olafur Baldursson; Thorarinn Gudjonsson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-18       Impact factor: 2.416

6.  Nuclear import of cutaneous beta genus HPV8 E7 oncoprotein is mediated by hydrophobic interactions between its zinc-binding domain and FG nucleoporins.

Authors:  Zeynep Onder; Junona Moroianu
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

7.  Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.

Authors:  Oliver Bischof; Karim Nacerddine; Anne Dejean
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 8.  Oncogenic Epstein-Barr virus recruits Nm23-H1 to regulate chromatin modifiers.

Authors:  Saurabh Pandey; Erle S Robertson
Journal:  Lab Invest       Date:  2017-10-16       Impact factor: 5.662

9.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

10.  Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein.

Authors:  Alixandra A Knapp; Patrick M McManus; Katy Bockstall; Junona Moroianu
Journal:  Virology       Date:  2008-11-08       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.